| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/27/2008 | CA2662848A1 2-aryl-6-phenylimidazo[1,2-.alpha.]pyridine derivatives, preparation thereof and therapeutic use thereof |
| 03/27/2008 | CA2662838A1 Oxindole derivatives |
| 03/27/2008 | CA2662773A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 03/27/2008 | CA2662673A1 Phenyl derivatives and their use as immunomodulators |
| 03/27/2008 | CA2662065A1 Dbait and uses thereof |
| 03/27/2008 | CA2660795A1 Optimized antibodies that target hm1.24 |
| 03/27/2008 | CA2646911A1 2- substituted-1alpha, 25-dihydroxy-19,26,27-trinor vitamin d analogs and uses thereof |
| 03/26/2008 | EP1903057A2 Lipoprotein-regulating medicaments |
| 03/26/2008 | EP1903054A2 Pharmaceutical compound containing a stabilised mRNA which is optimised for translation in its coded areas |
| 03/26/2008 | EP1902732A1 Prophylactic/therapeutic agent for her2-expressing cancer |
| 03/26/2008 | EP1902729A1 Int6 PROTEIN INVOLVED IN HYPOXIA STRESS INDUCTION AND USE THEREOF |
| 03/26/2008 | EP1902722A1 Agent for elevating adiponectin concentration |
| 03/26/2008 | EP1902065A2 Cyclic amide derivatives inhibitors of the inhibitor of apoptosis proteins, their preparation, and their use |
| 03/26/2008 | EP1902054A1 Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof and the therapeutic application of the same |
| 03/26/2008 | EP1902040A2 Polymorphic forms of (s)-1-cyanobutan-2-yl (s)-1-(3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) phenyl) ethylcarbamate |
| 03/26/2008 | EP1902037A1 2,4-diamino-pyrimidines used as aurora inhibitors |
| 03/26/2008 | EP1902032A1 Pharmaceutical compounds |
| 03/26/2008 | EP1902027A1 3-spir0cycl0pr0pyl2-0xind0le kinase inhibitors |
| 03/26/2008 | EP1902025A1 Kinase inhibitors |
| 03/26/2008 | EP1902024A2 Kinase inhibitors |
| 03/26/2008 | EP1901758A1 Active fraction of a polar solvent extract from the latex of euphorbiaceae plants |
| 03/26/2008 | EP1901754A2 Combination therapy of cancer with azd2171 and gemcitabine |
| 03/26/2008 | EP1901750A2 Tumor treatment with gliotoxin derivatives |
| 03/26/2008 | EP1901748A1 Angiogenesis inhibitors |
| 03/26/2008 | EP1901738A1 Wortmannin analogs and methods of using same in combination with chemotherapeutic agents |
| 03/26/2008 | EP1901729A1 Pharmaceutical formulations of hdac inhibitors |
| 03/26/2008 | EP1729786A4 Administration of cisplatin by inhalation |
| 03/26/2008 | EP1613619B1 Quinazoline derivatives for treatment of cancer |
| 03/26/2008 | EP1509524B1 Xanthine phosphodiesterase v inhibitor polymorphs |
| 03/26/2008 | EP1455790B1 Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition |
| 03/26/2008 | EP1309330B1 Photosensitizers with ligand targeting properties for tumor therapy |
| 03/26/2008 | EP1248847B1 Irak-4: compositions and methods of use |
| 03/26/2008 | EP1003750B1 Methods of preparing and purifying 9-nitro-20-camptothecin |
| 03/26/2008 | CN101151371A Retrotransposon inhibition in therapy |
| 03/26/2008 | CN101151278A CD20 antibody variants and uses thereof |
| 03/26/2008 | CN101151274A ROR alpha for promoting the induction of Bmal1 expression |
| 03/26/2008 | CN101151273A Acid addition salts of Ac-PHSCN-NH2 |
| 03/26/2008 | CN101151268A Hydrazinocarbonyl-thieno[2,3-c]pyrazoles, preparation method, compositions containing same and use |
| 03/26/2008 | CN101151261A Pyrimidine compounds having tie2 (TEK) inhibitory activity |
| 03/26/2008 | CN101151259A Heteroaryl urea derivatives useful for inhibiting CHKI |
| 03/26/2008 | CN101151258A Pyrimidine derivatives for treatment of hyperproliferative disorders |
| 03/26/2008 | CN101151045A Methods for suppressing neovascularization using EphrinB2 |
| 03/26/2008 | CN101151020A Adjuvanting material |
| 03/26/2008 | CN101148681A Targeted coexpression p53 and Mda-7 recombination adenovirus |
| 03/26/2008 | CN101148667A Preparation and use for affinity human albumin nucleic acid aptamer |
| 03/26/2008 | CN101148666A Nucleic acid aptamer with high specificity and high affinity to human breast carcinoma tissue, preparation method and application thereof |
| 03/26/2008 | CN101148661A Human papilloma virus 16 type coat protein virus-like particles, preparation method and use thereof |
| 03/26/2008 | CN101148659A Method of preparing recombination human source catalase and application thereof |
| 03/26/2008 | CN101148642A Probiotic/non-probiotic combinations |
| 03/26/2008 | CN101148483A Chitosan oligosaccharide-stearic acid grafting compound modified by folic acid, preparation method and application thereof |
| 03/26/2008 | CN101148478A Streptavidin-tumour putrescence factor alpha fusion protein |
| 03/26/2008 | CN101148477A Streptavidin-interleukins 2 fusion protein |
| 03/26/2008 | CN101148475A Human breast cancer resisting recombination immunotoxin M4G3/ScFv-PE40 |
| 03/26/2008 | CN101148474A Human resource vessel endothelium growth factor monoclonal antibody and preparation method thereof |
| 03/26/2008 | CN101148472A Tumour inhibitory gene or protein and application thereof |
| 03/26/2008 | CN101148467A Oligonucleotide and use thereof for treating lung cancer |
| 03/26/2008 | CN101148445A Method for preparing o-dihydroxyflavone-selenium complexes and medical use |
| 03/26/2008 | CN101148442A Histone deacetylase inhibitor and its preparation method and use |
| 03/26/2008 | CN101148437A Biinomenine derivative connected with C-C bond, preparation method and application thereof |
| 03/26/2008 | CN101147803A Anti Toll-like receptor 2 antibody inhibiting tumor metastasis use |
| 03/26/2008 | CN101147801A Application of dexoyribozyme of target EBV-LMP1 in preparing medicine for treating EBV corresponding solid tumor |
| 03/26/2008 | CN101147785A Medicinal preparation for preventing tumor |
| 03/26/2008 | CN101147776A Medicine preparation for treating cervical cancer and cervical erosion |
| 03/26/2008 | CN101147756A Medicinal composition containing total alooerine and licorice total flavone |
| 03/26/2008 | CN101147733A Application of chlorogenic acid in preparing medicine with treating woman organ tumor function |
| 03/26/2008 | CN101147732A Application of chlorogenic acid in preparing medicine with preventing and treating nasopharyngeal cancer function |
| 03/26/2008 | CN101147727A Curcumol submicron emulsion and preparation method and preparation thereof |
| 03/26/2008 | CN100376680C Dual target effected chimera recombinant, its construction method and application |
| 03/26/2008 | CN100376599C Recombining single chained three specific antibodies of anti CCA, anti CD 3, anti CD 28 through genetic engineering |
| 03/26/2008 | CN100376583C Esters in position 20 of camptothecins |
| 03/26/2008 | CN100376581C [1,4]diazocino [7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents |
| 03/26/2008 | CN100376579C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and use in treating |
| 03/26/2008 | CN100376576C Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives |
| 03/26/2008 | CN100376573C 1,3-dihydroimidazole fused-ring compound |
| 03/26/2008 | CN100376570C Dioxolane analogs for improved inter-cellular delivery |
| 03/26/2008 | CN100376569C Inhibitors of farnesyl protein transferase |
| 03/26/2008 | CN100376567C Qinazoline derivatives as VEGF inhibitors |
| 03/26/2008 | CN100376530C Vitamin D analogues |
| 03/26/2008 | CN100376291C Porous drug matrices and methods of manufacturing the same |
| 03/26/2008 | CN100376290C Antigenic peptides derived from telomerase |
| 03/26/2008 | CN100376288C Improvement of T cell mediated immunity |
| 03/26/2008 | CN100376249C Liposome of doxorubicin, and prepration method and application thereof |
| 03/26/2008 | CN100376244C Use of non-steroidal sulphamate compound in the preparation of medicine for treating tumor |
| 03/26/2008 | CN100376242C 2-aryl-propionic acid and medicine composition containing same |
| 03/25/2008 | US7348440 Mitotic kinesin inhibitors |
| 03/25/2008 | US7348433 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction |
| 03/25/2008 | US7348431 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 03/25/2008 | US7348426 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 03/25/2008 | US7348419 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications |
| 03/25/2008 | US7348413 Monoclonal antibodies for use in diagnosis, prevention and treatment of cell proliferfative disorders; immunotherapy; immunodiagnostics |
| 03/25/2008 | US7348400 α-conotoxin peptides with analgesic properties |
| 03/25/2008 | US7348359 Retinoid X receptor modulators |
| 03/25/2008 | US7348342 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent |
| 03/25/2008 | US7348339 2-(4-amino-furazan-3-yl)-1-ethyl-N-[(2R)-2-morpholinylmethyl]-1H-imidazo[4,5-c]pyridine-7-carboxamide; Mitogen- and Stress-Activated Protein (MSK) and Rho (guanosine triphosphate) 1 or 2 kinase inhibitor; neurodegenerative diaeases; antiinflammatory, anticarcinogenic, antiviral and antibacterial agent |
| 03/25/2008 | US7348336 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct |
| 03/25/2008 | US7348333 Treating bone disorder caused by osteoclasts, tumor growth and tumor metastasis, prophylaxis of cardiovascular disorders, nephropathies or retinopathies |
| 03/25/2008 | US7348330 1-azabicyclo [2,2,2] octan-3-one derivatives |
| 03/25/2008 | US7348327 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 03/25/2008 | US7348325 Pyrrolotriazine kinase inhibitors |
| 03/25/2008 | US7348320 lower toxicity and higher selectivity |